Examples of A&R License Agreement in a sentence
In consideration for the MSK A&R License Agreement, the Company issued 8,799 shares to MSK.
Pursuant to a side letter to the MSK A&R License Agreement, dated May 25, 2017 (the “MSK Side Letter”), MSK converted the next milestone payment of $0.2 million, which was due June 30, 2017, into shares.
During the years ended December 31, 2022 and 2021, we incurred $17.3 million and $25.0 million, respectively, of research and development expenses towards licensing fees.On October 6, 2022, we entered into an amended and restated license agreement, (the "A&R License Agreement"), with Pfizer, which amends and restates the Pfizer License Agreement.
In connection with the MSK A&R License Agreement, the Company issued 74,795 shares to MSK.
On October 6, 2022, the Company entered into the A&R License Agreement with Pfizer, which amends and restates the Pfizer License Agreement.
Under the Second MSK A&R License Agreement, the Company and MSK extended the dates for the Company to have obtained necessary financing, and certain milestone dates, in exchange for increased milestone payments, clarification regarding MSK’s anti-dilution rights, and termination of the MSK Side Letter dated May 25, 2017.
The Company assessed the milestone and royalty events under A&R License Agreement as of March 31, 2023 and 2022, and determined that no such amounts were required.LegoChem Biosciences, Inc.
During the three months ended March 31, 2023, in accordance with the terms of the A&R License Agreement, the Company paid $8.0 million to Pfizer in January 2023 and issued 1,811,594 shares of its common stock in March 2023.
We talked, at times, about the difficulties of being partners with specific practice responsibilities and being parents— but we never, once, whatever our contractual status, needed to moan about exploitation.There has been a lot of press coverage recently about salaried doctors.
Pursuant to the A&R License Agreement, Pfizer granted to the Company exclusive worldwide rights under Pfizer’s FACT Platform technology to develop and commercialize ADC product candidates directed to certain licensed targets, including PYX-201 and PYX-203, and products containing the ADC product candidates.